Aug 15
Opportunity
Participants expect a simple and convenient experience participating on clinical trials. To accomplish this goal, sponsors should consider the type, design and delivery of device (e.g., personal device, provided by study, etc.) for participants to achieve accessibility, flexibility, convenience and maintain privacy.
Considerations to Help Action the Opportunity
- Understand if the clinical trial design supports the applications of digital patient solutions
- Understand the needs and preferences of the participants taking part in the trial
- Does the population have access to devices and data plans, or would they need these to be provisioned?
- What devices would participants already have that could be used for clinical trials (e.g., wearables / sensors, glucometers, weighing scales, phones / tablets, etc.)?
- Understand impact on health equity (i.e., geographic, socioeconomic barriers) when implementing digital solutions
- Partner with sites to gain their input on the impact of multiple services, training, and technology implementation
- Understand how the device may impact data integrity, regulatory landscape, site implementation and overall costs
- Define how technology is designed, communicated and delivered for / to participants
- Define backup options (e.g., when a participant is unable to connect to device)
Value and Potential Benefits
- Increases access and ease of participation for participants on clinical trials by potentially reducing the number of site visits
- Allows for more robust datasets with improved data compliance and quality by enabling direct entry and near real-time review of data
Related Blog Posts
Redesigning Clinical Trials Using Artificial Intelligence
While tech evangelists often tout artificial intelligence (AI) as healthcare’s silver bullet, the reality in clinical trials is more complex. Adoption has been cautious, shaped as much by concerns around trust and governance as by technical hurdles. Still, beneath the surface, methodical innovation is gaining momentum. AI is beginning to reshape how trials are designed,…
How Pandemic-Era Ingenuity Fuels the Future of Clinical Trials
It’s hard to believe that just five years ago, the clinical research industry found itself scrambling to adapt overnight. The COVID-19 pandemic ground global health systems to a halt and forced us all to move faster and more collaboratively than ever before. Read the full article by Allison Cuff Shimooka from The Medicine Maker here.
Science is Moving—Clinical Trials Must Catch Up
Clinical research has never been more capable of reaching new frontiers. The science is here. The technology is here. But the approach to trial design and execution hasn’t kept pace. The clinical research ecosystem proceeds cautiously for good reasons—patient safety chief among them. But too often, we’re held back by fixed mindsets and outdated processes.…